Maverick Labs, Inc.


Maverick Labs is a U.S.-based biotechnology and materials science company specializing in advanced protein design, synthetic biology, and microbial engineering. The company operates through three tightly integrated subsidiaries—Maverick Metals, Maverick Energy, and the Maverick Bio-Gene Therapy Translational Unit—each of which applies a shared technological foundation to tackle critical challenges across national defense, energy independence, and strategic material access. Together, they develop scalable, field-ready solutions that reinforce the United States’ industrial resilience and military readiness through biotechnology-driven innovation.

Maverick Metals

Maverick Labs, Inc.

Maverick Labs, Inc. is currently seeking investment

Maverick Labs, Inc. is seeking a seed investment in the range of 5m-20m

All Investment-seeking Members

What We Do

Gene Therapy for Rapid Muscle Recovery and Tactical Performance

Maverick Bio’s AAV9-IGF1 gene therapy platform delivers skeletal muscle–specific enhancement peptide expression via a single IV injection. This enables rapid, targeted muscle growth without affecting serum enhancement peptide levels or off-target organs like the liver and heart. The result is fast recovery and enhanced physical capacity, with a safety profile unmatched by systemic hormone therapies.

Fentanyl-Class Prophylaxis and Overdose Protection

This high-affinity monoclonal antibody provides long-lasting prophylactic protection against fentanyl and its ultra-potent analogs (e.g., carfentanil, sufentanil). It neutralizes opioid molecules in the bloodstream before they can cross the blood–brain barrier, offering life-saving protection even at lethal exposure levels. Crucially, the antibody does not interfere with naloxone, allowing for combined use in emergency settings.


Regenerative Medicine

Routes of Administration

Digital Health Technologies


Key People

Eric Hererra

CEO

LinkedIn

Jesse Evans

COO

LinkedIn

News & Updates

Maverick Metals is supported by Y Combinator, a leading startup accelerator, underscoring its innovative approach and growth potential in the field of metal extraction technologies.

LithX enables heap leaching of chalcopyrite and other refractory sulfides, while also solubilizing valuable byproducts like molybdenum, gold, and silver. This event highlights how Maverick Metals is transforming copper processing and turning low-grade ore, tailings, and smelter slag into high-value feedstock.

Showcases how LithX improves recovery and enhances profitability in critical metal extraction, even from slag and refractory materials, without the need for costly infrastructure or harsh acids.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.